A new COVID-19 variant known as 'razor blade throat' is causing concern due to painful sore throats. However, experts say it poses a low risk. Learn more about its spread and symptoms.
A new COVID-19 variant nicknamed 'razor blade throat' is causing concern due to its painful sore throat symptom. However, experts say it's not more severe than previous variants. Here's what you need to know.
The NB.1.8.1 variant of COVID-19 is rapidly spreading in the U.S., now accounting for 37% of cases. Experts warn it may lead to a summer surge, although its severity remains uncertain.
Experts are raising alarms about the new Covid variant 'Nimbus', which is spreading rapidly across the US. With symptoms like 'razor blade throat', this variant may be the most infectious yet. Learn what it means for public health and vaccine effectiveness.
A new COVID-19 variant, NB.1.8.1, is spreading quickly in California, leading health experts to warn of a potential summer surge. Learn about the symptoms, vaccine effectiveness, and what residents should know.
The U.S. has approved Moderna's new COVID-19 vaccine, mNexspike, specifically for high-risk groups. This innovative option offers a lower dose while maintaining effectiveness, marking a pivotal step in the fight against coronavirus.
In a surprising move, the HHS has terminated a $590 million contract with Moderna for H5 avian influenza vaccine development, raising alarms among health experts amidst rising H5N1 threats.
The measles outbreak that started in Gaines County has now reached the Dallas-Fort Worth area, with new cases reported in Collin and Rockwall counties, raising concerns about vaccination rates and public health.
The U.S. is facing a severe measles outbreak, with cases exceeding 1,000 for the first time in three decades. Health officials warn of the risks as vaccination rates decline, especially among young children.
A measles outbreak in Texas has led to over 800 reported cases in the U.S. this year, raising concerns about vaccine effectiveness and breakthrough infections among the vaccinated population.
